These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 20020587

  • 1. 9 years follow-up of a patient with pituitary form of resistance to thyroid hormones (PRTH): comparison of two treatment periods of D-thyroxine and triiodothyroacetic acid (TRIAC).
    Guran T, Turan S, Bircan R, Bereket A.
    J Pediatr Endocrinol Metab; 2009 Oct; 22(10):971-8. PubMed ID: 20020587
    [Abstract] [Full Text] [Related]

  • 2. Prenatal diagnosis of thyroid hormone resistance.
    Asteria C, Rajanayagam O, Collingwood TN, Persani L, Romoli R, Mannavola D, Zamperini P, Buzi F, Ciralli F, Chatterjee VK, Beck-Peccoz P.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):405-10. PubMed ID: 10022392
    [Abstract] [Full Text] [Related]

  • 3. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance.
    Radetti G, Persani L, Molinaro G, Mannavola D, Cortelazzi D, Chatterjee VK, Beck-Peccoz P.
    Thyroid; 1997 Oct; 7(5):775-8. PubMed ID: 9349583
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic analyses and evaluation of peripheral parameters of thyroid hormone action for the differential diagnosis of RTH. A novel heterozygous missense mutation (M334T) discovered.
    Mannavola D, Vannucchi G, Fugazzola L, Cerutti N, Persani L, Beck-Peccoz P.
    J Endocrinol Invest; 2002 Feb; 25(2):RC4-6. PubMed ID: 11929097
    [Abstract] [Full Text] [Related]

  • 7. TRIAC (3,5,3'-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine.
    Mechelany C, Schlumberger M, Challeton C, Comoy E, Parmentier C.
    Clin Endocrinol (Oxf); 1991 Aug; 35(2):123-8. PubMed ID: 1934526
    [Abstract] [Full Text] [Related]

  • 8. Successful therapy with 3,5,3'-triiodothyroacetic acid (TRIAC) in pituitary resistance to thyroid hormone.
    Darendeliler F, Baş F.
    J Pediatr Endocrinol Metab; 1997 Aug; 10(5):535-8. PubMed ID: 9401912
    [No Abstract] [Full Text] [Related]

  • 9. Pituitary resistance to thyroid hormone caused by a novel mutation (H435A) in the thyroid hormone receptor beta: A case report.
    Yu C, Zhao J, Yao J, Wang H, Shang H, Zhang R, Cui Y, Wang L, Dong J, Liao L.
    Medicine (Baltimore); 2018 May; 97(21):e10544. PubMed ID: 29794730
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the metabolic and endocrine effects of 3,5,3'-triiodothyroacetic acid and thyroxine.
    Bracco D, Morin O, Schutz Y, Liang H, Jéquier E, Burger AG.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):221-8. PubMed ID: 8325946
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of pituitary resistance to thyroid hormone (PRTH) in an 8-year-old boy.
    Pohlenz J, Knöbl D.
    Acta Paediatr; 1996 Mar; 85(3):387-90. PubMed ID: 8696005
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Resistance to thyroid hormones].
    Jiskra J, Límanová Z.
    Cas Lek Cesk; 2014 Mar; 153(3):137-41. PubMed ID: 24968291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.